Neurocognitive impairment in lead-exposed children of andean lead-glazing workers

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 3, 2005, Pages 306-312

  Counter, S Allen ^a,b   Buchanan, Leo H ^c,d   Ortega, Fernando ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSIDAD SAN FRANCISCO DE QUITO   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ARTICLE; CHILD; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OCCUPATIONAL TOXICOLOGY; PERFORMANCE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK MANAGEMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WORKER;

ADULT; CERAMICS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION DISORDERS; COHORT STUDIES; ECUADOR; FEMALE; HUMANS; INTELLIGENCE TESTS; LEAD POISONING; MALE; OCCUPATIONAL EXPOSURE; PARENT-CHILD RELATIONS; RISK ASSESSMENT;

EID: 14944383700     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000155717.45594.65     Document Type: Article

References (37)

1. Counter SA, Buchanan LH, Laurell G, Ortega F. Field screening of blood lead levels in remote Andean villages. Neurotoxicology. 1998;19:871-878.
2. Counter SA, Buchanan LH, Ortega F. Amarisiriwardena C, Hu H. Environmental lead contamination and pediatric lead intoxication in an Ecuadorian Andean village. Int J Occup Environ Health. 2000;6:169-176.
3. National Research Council (NRC). Measuring Lead Exposure in Infants, Children, and Other Sensitive Populations. Washington, DC: National Academy Press: 1993.
4. Bouton CM, Frelin LP, Forde CE, Arnold Godwin H, Pevsner J. Synaptotagmin I is a molecular target for lead. J Neurochem. 2001;76:1724-1735.
5. De Gennaro LD. Lead and the developing nervous system. Growth Dev Aging. 2002;66:43-50.
6. Lidsky TI, Schneider JS. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 2003;126:5-19.
7. Needleman HL, Gunnoe C, Leviton A, et al. Deficits in psychologic and classroom performance of children with elevated dentin lead levels. N Engl J Med. 1979; 300:689-695.
8. Benetou-Marantidou A, Nakou S, Micheloyannis J. Neurobehavioral estimation of children with life-long increased lead exposure. Arch Environ Health. 1988;43: 392-395.
9. Dietrich KN, Succop PA, Bornschein R, et al. Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect. 1990;89:13-19.
10. Bellinger D. Learning and behavioral sequelae of lead poisoning. In: Pueschel SM, Linakis JG, Anderson AC, eds. Lead Poisoning in Childhood. Baltimore: Paul H. Brookes Publishing Inc Co; 1996:97-115.
11. Banks EC, Ferretti LE, Shucard DW. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology. 1997;18:237-282.
12. Dudek B, Merecz D. Impairment of psychological functions in children environmentally exposed to lead. Int J Occup Med Environ Health. 1997;10:37-46.
13. Counter SA, Buchanan LH, Rosas HD, Ortega F. Neurocognitive effects of chronic elevated blood lead levels in Andean children. J Neural Sci. 1998;160: 47-53.
14. Centers for Disease Control and Prevention (CDC). Preventing Lead Poisoning in Young Children: A Statement by the US Department of Health and Human Services. Atlanta: US Government Printing Office Atlanta (No. 537); 1991.
15. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics. 1992; 90:855-861.
16. Chiodo LM, Jacobson SW, Jacobson JL. Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol. 2004;26:359-371.
17. Schwartz J. Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. Environ Res. 1994;65: 42-55.
18. Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep. 2000;115:521-529.
19. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10μg per deciliter. N Engl J Med. 2003; 348:1517-1526.
20. Faust D, Brown J. Moderately elevated blood lead levels: effects on neuropsychologic functioning in children. Pediatrics. 1987;80:623-629.
21. Dietrich KN, Krafft KM, Bornschein RL, et al. Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics. 1987;80:721-730.
22. Wasserman GA, Liu X, Popovac D, et al. The Yugoslavia prospective lead study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol. 2000;22:811-818.
23. Rogan WJ, Dietrich KN, Ware JH, et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med. 2001;344:1421-1426.
24. Raven J, Raven JC, Court JH. Manual for Raven's Progressive Matrices and Vocabulary Scales: Section 2 Coloured Progressive Matrices. London: Oxford Psychologists Press Ltd; 1998.
25. Raven J, et al. Manual for Raven's Progressive Matrices and Vocabulary Scales: Research Supplement No. 3. London: Oxford Psychologists Press Ltd; 2000.
26. Sattler JM. Assessment of Children, 3rd ed. San Diego: Jerome M. Sattler, Publisher, Inc; 1986.
27. Sizemore OJ, Amler RW. Characteristics of ATSDR's adult and pediatric environmental neurobehavioral test batteries. Neurotoxicology. 1996;17:229-236.
28. Counter SA, Ortega F, Shannon MW, Buchanan LH. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure. Int J Occup Environ Health. 2003;9:164-168.
29. Counter SA, Buchanan LH, Ortega F. Current pediatric and maternal lead levels in blood and breast milk in Andean inhabitants of a lead-glazing enclave. J Occup Environ Med. 2004;46:967-973.
30. Tong S, Baghurst PA, Sawyer MG, Burns J, McMichael AJ. Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie cohort study. JAMA.. 1998;280:1915-1919.
31. Jutras B, Gange BP. Auditory sequential organization among children with and without a hearing loss. J Sp Lang Hear Res. 1999;42:553-567.
32. Weichbold V, Herka H. Performance of hearing impaired children on Raven's Coloured Progressive Matrices Test. Int J Pediatr Otorhinolaryngol. 2003;67: 1213-1217.
33. Counter SA, Buchanan LH, Ortega F, Rifai N. Blood lead and hemoglobin levels in Andean children with chronic lead intoxication. Neurotoxicology. 2000;21: 301-308b.
34. Schwartz BS, Byung-Kook L, Gap-Soo L, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000;108:949-954.
35. Tong S, Lu Y. Identification of confounders in the assessment of the relationship between lead exposure and child development. Ann Epidemiol. 2001;11: 38-45.
36. Mink, PJ, Goodman M, Barraj LM, Imrey H, Kelsh MA, Yager J. Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children. Epidemiology. 2004;15:385-393.
37. Bellinger DC. Assessing environmental neurotoxicant exposures and child neurobehavior: confounded by confounding? Epidemiology. 2004;15:383-384.